Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Clinton Cary

Clinton Cary MD, MPH

Assistant Professor, Department of Urology, Indiana University School of Medicine, Research Scientist, Indiana University Center for Health Services and Outcomes Research, Indianapolis, Indiana
Dr. Cary is a research scientist in Regenstrief Institute's William M. Tierney Center for Health Services Research and Assistant Professor in the Department of Urology at Indiana University School of Medicine. Dr. Cary provides direct medical and surgical care for general urology and urologic oncology patients. His research efforts are focused on improving the health of patients with urologic cancers through health services and outcomes research in testis, bladder, and prostate cancer. He has an active pilot study in progress to assess utilization rates of single dose intravesical chemotherapy in patients with non-muscle invasive bladder cancer in a population-based environment.

Disclosures

Dr. Cary reports no financial disclosures.

Recent Contributions to PracticeUpdate:

  1. Testis-Sparing Surgery for Benign Testicular Masses
  2. Serum miRNA Predicts Viable Disease Post Chemotherapy in Nonseminoma Testicular Germ Cell Tumors
  3. Testicular Tumor Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Under Surveillance

Recently Updated